About Exvivodynamics
Exvivodynamics is a company based in New York (United States) founded in 2013. Exvivodynamics operates in a competitive market with competitors including Haemonetics, Vetex Medical, MediSieve, Immutrix Therapeutics and Hemostasis, among others.
- Headquarter New York, United States
- SectorsHealthcare
- Email••••••••
- Website exvivodynamics.com
Competitors of Exvivodynamics
Exvivodynamics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Haemonetics, Vetex Medical, MediSieve, Immutrix Therapeutics and Hemostasis, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| haemonetics.com | 1971 | Braintree, United States | – | 3,034 | Hematology products and solutions are provided for medical applications. | |
| vetexmedical.com | 2016 | Galway, Ireland | – | – | Catheters for venous clot management and removal are developed. | |
| medisieve.com | 2014 | London, United Kingdom | $4.18M | 12 | Magnetic therapy is developed to treat blood-borne diseases. | |
| immutrix.com | 2009 | Rapid, United States | $14.02M | – | Blood cleansing treatment device | |
| hemostasisllc.com | 2006 | Saint Paul, United States | – | – | Develops and manufactures hemostatic products for surgical bleeding control and patient care. | |
| immunocept.com | 1999 | Denver, United States | $530,000 | – | Blood filtration therapy for severe sepsis is developed. | |
| straubmedical.com | 1997 | Vilters Wangs, Switzerland | – | – | Medical devices for treating peripheral vascular diseases are developed. | |
| fiveliters.com | 2022 | Dallas, United States | $500,000 | – | Developer of medical device for non-invasive neuromodulation of hemorrhaging |
Detailed competitors of Exvivodynamics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Exvivodynamics
10 companies that operate in the same segment as Exvivodynamics (Hematology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Catheter-based thrombectomy devices for vascular emboli removal are developed. | 2011 | Irvine, California, United States | USD 51.89 M | USD 493.63 M | 696 | |
Small activating RNA therapeutics are developed to restore gene function. | 2008 | London, England, United Kingdom | USD 460.41 M | USD 23.07 M | 37 | |
Small molecules are developed to treat hematologic and musculoskeletal disorders. | 2016 | Lexington, Kentucky, United States | USD 90 M | USD 244.06 M | 169 | |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders | 2016 | Menlo Park, California, United States | USD 442 M | – | 66 | |
Developer of therapeutics for the treatment of hematologic diseases | 2017 | Cambridge, Massachusetts, United States | USD 140 M | – | 84 | |
Gene therapy platform is developed for chronic disease treatments. | 2015 | Stevenage, Hertfordshire, United Kingdom | USD 273.69 M | USD 435.87 K | 152 | |
Novel anticoagulants for thrombosis treatment are developed. | 2019 | Cambridge, Massachusetts, United States | USD 250 M | – | 14 | |
Developer of therapies for treating hemochromatosis & beta thalassemia | 1989 | San Diego, California, United States | – | USD 75.72 M | 71 | |
Breakthrough therapies are developed for blood diseases and infections. | 2014 | Buffalo, New York, United States | USD 1 M | – | 22 | |
Hematology products and solutions are provided for medical applications. | 1971 | Braintree, Massachusetts, United States | – | USD 1.33 B | 3,020 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Exvivodynamics
Exvivodynamics was founded in 2013.
Exvivodynamics is headquartered in New York, United States. It is registered at New York, New York, United States.
Exvivodynamics was founded in 2013 in New York, United States, within the medical device sector. A filtration device has been developed to remove microparticles from blood intended for transfusion. These microparticles arise from hemolysis during blood storage, releasing free heme, hemoglobin, and iron that damage red blood cells. Consequences include iron overload, sepsis, organ damage, and potential morbidity in patients. Operations focus on enhancing transfusion safety through this technology.
Exvivodynamics's top competitors include Haemonetics, Vetex Medical and MediSieve.